InspireMD, Inc. Net Income Loss

• InspireMD, Inc. showed a decrease of -52.4% in Net Income Loss from 2024 to 2025.
• This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2011: -$2.28 million | Q4 2011: -$8.23 million | Q1 2012: -$3.14 million | Q3 2012: -$7.51 million | Q4 2012: -$1.92 million | Q1 2013: -$4.89 million | Q2 2013: -$14.95 million | Q3 2013: -$3.95 million | Q1 2014: -$5.97 million | Q2 2014: -$7.56 million | Q3 2014: -$6.78 million | Q1 2015: -$5.21 million | Q2 2015: -$3.88 million | Q3 2015: -$3.64 million | Q1 2016: -$2.25 million | Q2 2016: -$1.95 million | Q3 2016: -$2.00 million | Q1 2017: -$2.56 million | Q2 2017: -$2.29 million | Q3 2017: -$2.09 million | Q1 2018: -$2.39 million | Q2 2018: -$627.0 thousand | Q3 2018: -$2.01 million | Q1 2019: -$3.21 million | Q2 2019: -$2.21 million | Q3 2019: -$2.07 million | Q1 2020: -$1.98 million | Q2 2020: -$2.48 million | Q3 2020: -$2.23 million | Q1 2021: -$3.24 million | Q2 2021: -$3.51 million | Q3 2021: -$4.07 million | Q1 2022: -$4.48 million | Q2 2022: -$4.64 million | Q3 2022: -$4.53 million | Q1 2023: -$4.26 million | Q2 2023: -$5.08 million | Q3 2023: -$5.18 million | Q1 2024: -$7.03 million | Q2 2024: -$7.91 million | Q3 2024: -$7.89 million | Q1 2025: -$11.17 million | Q2 2025: -$13.15 million | Q3 2025: -$12.71 million.
• Over the full 17 years of available data (2009 to 2025), InspireMD, Inc.'s Net Income Loss has declined by 1,691.0%.
• Historical annual values: Fiscal year 2025: -$48.79 million | Fiscal year 2024: -$32.01 million | Fiscal year 2023: -$19.92 million | Fiscal year 2022: -$18.49 million | Fiscal year 2021: -$14.92 million | Fiscal year 2020: -$10.54 million | Fiscal year 2019: -$10.04 million | Fiscal year 2018: -$7.24 million | Fiscal year 2017: -$8.44 million | Fiscal year 2016: -$8.46 million | Fiscal year 2015: -$15.59 million | Fiscal year 2014: -$25.10 million | Fiscal year 2013: -$29.26 million | Fiscal year 2012: -$17.60 million | Fiscal year 2011: -$14.67 million | Fiscal year 2010: -$3.42 million | Fiscal year 2009: -$2.72 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026